Methods for providing differentiated stem cells
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C12N-005/00
C07H-021/02
C07H-021/04
C07H-021/00
출원번호
US-0783203
(2001-02-13)
발명자
/ 주소
Gold, Joseph D.
Lebkowski, Jane S.
출원인 / 주소
Geron Corporation
대리인 / 주소
Schiff, J. MichaelEarp, David J.
인용정보
피인용 횟수 :
63인용 특허 :
17
초록▼
This invention provides a system for producing differentiated cells from a stem cell population for use wherever a relatively homogenous cell population is desirable. The cells contain an effector gene under control of a transcriptional control element (such as the TERT promoter) that causes the gen
This invention provides a system for producing differentiated cells from a stem cell population for use wherever a relatively homogenous cell population is desirable. The cells contain an effector gene under control of a transcriptional control element (such as the TERT promoter) that causes the gene to be expressed in relatively undifferentiated cells in the population. Expression of the effector gene results in depletion of undifferentiated cells, or expression of a marker that can be used to remove them later. Suitable effector sequences encode a toxin, a protein that induces apoptosis, a cell-surface antigen, or an enzyme (such as thymidine kinase) that converts a prodrug into a substance that is lethal to the cell. The differentiated cell populations produced according to this disclosure are suitable for use in tissue regeneration, and non-therapeutic applications such as drug screening.
대표청구항▼
This invention provides a system for producing differentiated cells from a stem cell population for use wherever a relatively homogenous cell population is desirable. The cells contain an effector gene under control of a transcriptional control element (such as the TERT promoter) that causes the gen
This invention provides a system for producing differentiated cells from a stem cell population for use wherever a relatively homogenous cell population is desirable. The cells contain an effector gene under control of a transcriptional control element (such as the TERT promoter) that causes the gene to be expressed in relatively undifferentiated cells in the population. Expression of the effector gene results in depletion of undifferentiated cells, or expression of a marker that can be used to remove them later. Suitable effector sequences encode a toxin, a protein that induces apoptosis, a cell-surface antigen, or an enzyme (such as thymidine kinase) that converts a prodrug into a substance that is lethal to the cell. The differentiated cell populations produced according to this disclosure are suitable for use in tissue regeneration, and non-therapeutic applications such as drug screening. ation of IgG in Bovine Milk," J. Agric. Food Chem., 41:682-686 (1993). Lou et al., "One-Step Competitive Immunochromatographic Assay for Semiquantitative Determination of Lipoprotein(a) in Plasma," Clin. Chem., 39:619-624 (1993). Parsons et al., "Multianalyte Assay System Developed for Drugs of Abuse," Clin. Chem., 39:1899-1903 (1993). Rosenzweig et al., "Laser-Based Particle-Counting Microimmunoassay for the Analysis of Single Human Erythrocytes," Anal. Chem., 66:1771-1776 (1994). Reeves et al., "Novel Optical Measurement Approach for the Quantitation of Liposome Immunomigration Assays," Analytical Letters, 28:2347-2352 (1995). Roberts et al., "Investigation of Liposome-Based Immunomigration Sensors for the Detection of Polychlorinated Biphenyls," Analytical Chemistry, 67:482-491 (1995). Siebert et al., "Liposome Immunomigration Field Assay Device for Alachlor Determination," Analytica Chimica Acta, 282:297-305 (1993). Niwa et al., "Electrochemical Behavior of Reversible Redox Species at Interdigitated Array Electrodes with Different Geometries: Consideration of Redox Cycling and Collection Efficiency," Anal. Chem., 62:447-452 (1990). Niwa et al., "Small-Volume Voltammetric Detection of 4-Aminophenol with Interdigitated Array Electrodes and Its Application to Electronchemical Enzyme Immunoassay," Anal. Chem., 65:1559-1563 (1993). Rule et al., "Rapid Method for Visual Identification or Specific DNA Sequences Based on DNA-Tagged Liposomes,"Clin. Chem., 42(8):1206-1209 (1996). Rule et al., "Characteristics of DNA-Tagged Liposomes Allowing Their Use in Capillary-Migration, Sandwich-Hybridization Assays," Anal. Biochem., 244:260-269 (1997). Martorell et al., "Liposome Dehydration on Nitrocellulose and its Application in a Biotin Immunoassay," Analytical Biochemistry 271(2):177-185 (1999). Madden et al., "Protection of Large Unilamellar Vesicles by Trehalose During Dehydration: Retention of Vesicle Contents," Biochim. et Biophys. Acta, 817:67-74 (1985). Crowe et al., "Preservation of Freeze-Dried Liposomes by Trehalose," Archives of Biochem. and Biophys., 242:240-247 (1985). Harrigan et al., "Protection of Liposomes During Dehydration or Freezing," Chemistry and Physics of Lipids, 52:139-149 (1990). Crowe et al., "Preservation of Liposomes by Freeze-Drying," in Liposome Technology, Gregoriadis, ed., CRC Press, Boca Raton, pp. 229-252 (1993). Ausborn et al., "The Protective Effect of Free and Membrane-Bound Cryoprotectants During Freezing and Freeze-Drying of Liposomes," J. of Controlled Release, 30:105-116 (1994). Durst, "Development of a Liposome-Enhanced Assay Format for the Detection of Specific Nucleic Acid Sequences," Cornell Center for Advanced Technology (CAT)--Biotechnology Program, Research Directory (1994-1995) (abstract). Umeda et al., "Liposome Immune Lysis Assay (LILA). Application of Sandwich Method to Determine a Serum Protein Component With Antibody-Bearing Liposomes," J. Immunol. Methods, 95:15-21 (1986). Umeda et al., "A Novel Liposome Immune Lysis Assay (LILA) for Determination of CRP Antigen Using Two Monoclonal Antibodies Recognizing Different Antigenic Determinants," Acta Med. Okayama, 48(6):299-304 (1994). Ho et al., "Interactions of Target-Sensitive Immunoliposomes with Herpes Simplex Virus," J. Biol. Chem., 262(29):13979-13984 (1987). Singh et al., "Application of Antibody and Fluorophore-Derivatized Liposomes to Heterogeneous Immunoassays for D-dimer," Biotechnol. Prog., 12:272-280 (1996). Kung et al., "Large Liposome Agglutinaton Technique for the Serological Detection of Syphilis," J. Immunol. Methods, 90:189-196 (1986).
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (17)
Taketo Makoto (Bar Harbor ME), Cellular enhancer for expressing genes in undifferentiated stem cells.
Weiss Samuel,CAX ; Reynolds Brent,CAX ; Hammang Joseph P. ; Baetge E. Edward, In vitro growth and proliferation of multipotent neural stem cells and their progeny.
Gage Fred H. (La Jolla CA) Rosenberg Michael B. (San Diego CA) Friedmann Theodore (La Jolla CA), Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system.
Orgill Dennis P. ; Butler Charles E. ; Barlow Mark ; Ritterbush Scott ; Yannas Ioannis V. ; Compton Carolyn C., Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft.
Hedrick, Marc H.; Fraser, John K.; Schulzki, Michael J.; Byrnes, Bobby; Carlson, Grace; Schreiber, Ronda Elizabeth; Wulur, Isabella, Automated methods for isolating and using clinically safe adipose derived regenerative cells.
Hyde, Roderick A.; Kindsvogel, Wayne R.; McKnight, Gary L., Compositions and methods including cytotoxic B lymphocyte cell line expressing exogenous membrane immunoglobulin different from secreted immunoglobulin.
Hyde, Roderick A.; Kindsvogel, Wayne R., Compositions and methods including recombinant B lymphocyte cell line including an exogenously incorporated nucleic acid expressing an exogenous membrane immunoglobulin reactive to a first antigen and including an endogenous gene expressing an endogenous secreted immunoglobulin reactive to a second antigen.
Hyde, Roderick A.; Kindsvogel, Wayne R., Compositions and methods including recombinant B lymphocyte cell line including an exogenously incorporated nucleic acid expressing an exogenous membrane immunoglobulin reactive to a first antigen and including an endogenous gene expressing an endogenous secreted immunoglobulin reactive to a second antigen.
Hyde, Roderick A.; Kindsvogel, Wayne R., Compositions and methods including recombinant B lymphocyte cell line including an exogenously incorporated nucleic acid expressing an exogenous membrane immunoglobulin reactive to a first antigen and including an endogenous gene expressing an endogenous secreted immunoglobulin reactive to a second antigen.
Hyde, Roderick A.; Kindsvogel, Wayne R., Compositions and methods including recombinant B lymphocyte cell line including an exogenously incorporated nucleic acid expressing an exogenous membrane immunoglobulin reactive to a first antigen and including an endogenous gene expressing an endogenous secreted immunoglobulin reactive to a second antigen.
Hyde, Roderick A.; Kindsvogel, Wayne R., Compositions and methods including recombinant B lymphocyte cell line including at least one endogenous gene expressing at least one endogenous membrane immunoglobulin reactive to a first antigen and including at least one exogenously incorporated nucleic acid expressing at least one exogenous secreted immunoglobulin reactive to a second antigen.
Hyde, Roderick A.; Kindsvogel, Wayne R., Compositions and methods including recombinant B lymphocyte cell line including at least one endogenous gene expressing at least one endogenous membrane immunoglobulin reactive to a first antigen and including at least one exogenously incorporated nucleic acid expressing at least one exogenous secreted immunoglobulin reactive to a second antigen.
Hyde, Roderick A.; Kindsvogel, Wayne R., Compositions and methods including recombinant B lymphocyte cell line including at least one endogenous gene expressing at least one endogenous membrane immunoglobulin reactive to a first antigen and including at least one exogenously incorporated nucleic acid expressing at least one exogenous secreted immunoglobulin reactive to a second antigen.
Mandalam, Ramkumar; Xu, Chunhui; Gold, Joseph D.; Carpenter, Melissa K., Human embryonic stem cells genetically modified to contain a nucleic acid and cultured with fibroblast growth factor.
Gold, Joseph D; Lebkowski, Jane S, Isolated in vitro cell population comprising primate pluripotent stem cells containing a nucleic acid construct and differentiated progeny of the pluripotent stem cells.
Hedrick, Marc H.; Fraser, John K.; Riley, Susan Lynn; Schreiber, Ronda Elizabeth, Methods of using adipose derived regenerative cells to promote restoration of intevertebral disc.
Fraser, John K.; Hedrick, Marc H.; Zhu, Min; Strem, Brian M.; Daniels, Eric; Wulur, Isabella, Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions.
Fraser, John K.; Hedrick, Marc H.; Daniels, Eric, Methods of using adipose-derived regenerative cells in the treatment of peripheral vascular disease and related disorders.
Hedrick, Marc H.; Fraser, John K.; Riley, Susan Lynn; Schreiber, Ronda Elizabeth, Methods of using regenerative cells in the treatment of musculoskeletal disorders.
Hariri, Robert J.; Stirling, David I.; Moutouh-De Parseval, Laure A.; Chan, Kyle W. H., Modulation of stem and progenitor cell differentiation, assays, and uses thereof.
Hariri,Robert J.; Stirling,David I.; Moutouh De Parseval,Laure A.; Chan,Kyle W. H., Modulation of stem and progenitor cell differentiation, assays, and uses thereof.
Mandalam, Ramkumar; Xu, Chunhui; Gold, Joseph D.; Carpenter, Melissa K., Primate pluripotent stem cell expansion without feeder cells and in the presence of FGF and matrigel or Engelbreth-Holm-Swarm tumor cell preparation.
Hedrick, Marc H.; Fraser, John K.; Schulzki, Michael J.; Byrnes, Bobby; Carlson, Grace; Schreiber, Ronda Elizabeth; Wulur, Isabella, Systems and methods for isolating and using clinically safe adipose derived regenerative cells.
Hedrick, Marc H.; Fraser, John K.; Schulzki, Michael J.; Byrnes, Bobby; Carlson, Grace; Shanahan, Robert K., Systems and methods for separating and concentrating adipose derived stem cells from tissue.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.